PFCS
OCUL icon

Pale Fire Capital SE’s Ocular Therapeutix OCUL Stock Holding History

Pale Fire Capital SE’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-530,135
Closed -$4.92M – 63
2025
Q2 		$4.92M Buy
530,135
+90,748
+21% +$710K 0.5% 24
2025
Q1 		$3.22M Sell
439,387
-5,426
-1% -$41.7K 0.38% 21
2024
Q4 		$3.8M Buy
444,813
+6,613
+2% +$64.5K 0.86% 12
2024
Q3 		$3.81M Buy
+438,200
New +$3.61M 0.6% 14

Other funds holding OCUL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Pale Fire Capital SE's OCUL Position: Q3 2025 in Review

Pale Fire Capital SE sold out of Ocular Therapeutix (OCUL) in Q3 2025, closing a stake of 530,135 shares — an estimated $4.92M sold.

Pale Fire Capital SE first reported a position in OCUL in Q3 2024 and held it in 4 quarters. The position peaked at $4.92M in Q2 2025. 216 funds tracked by Wall St. Rank hold OCUL as of Q3 2025.

  • Pale Fire Capital SE reported no remaining Ocular Therapeutix position as of Q3 2025 after selling out during the quarter.
  • Pale Fire Capital SE sold 530,135 Ocular Therapeutix shares in Q3 2025, an estimated $4.92M.
  • Pale Fire Capital SE first reported a position in Ocular Therapeutix in Q3 2024 and held it in 4 quarters.
  • Pale Fire Capital SE's Ocular Therapeutix position peaked at $4.92M in Q2 2025.
  • 216 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q3 2025.

Based on Pale Fire Capital SE's 13F filing for Q3 2025, filed 13 Nov 2025.